| |
| The summaries are free for public
use. The Chronic Liver Disease
Foundation will continue to add and
archive summaries of articles deemed
relevant to CLDF by the Board of
Trustees and its Advisors. |
| |
|
|
| Abstract Details |
 |
|
| |
| |
| |
|
|
| |
Prognostic Factors in Hepatitis C Patients with a Single Small Hepatocellular Carcinoma after Radiofrequency Ablation |
|
|
|
|
| |
Toshikuni N, Takuma Y, Goto T, Yamamoto H. Hepatogastroenterology. 2012 Jun 8;59(120). doi: 10.5754/hge12394. [Epub ahead of print] |
|
| |
|
|
| |
Abstract
Background/Aims: Hepatitis C is a major cause of hepatocellular carcinoma (HCC). Radiofrequency ablation (RFA) has been widely performed as a curative treatment for small HCC. The knowledge of prognostic factors in hepatitis C patients with small HCC after RFA is therefore important. Methodology: One hundred consecutive hepatitis C patients with a single HCC 3cm or less treated with RFA were enrolled. The cumulative recurrence and survival rates were calculated using Kaplan-Meier analysis. Prognostic factors were investigated using the Cox proportional hazard model. Results: Five-year local and distant intrahepatic recurrence rates were 10.4% and 70.9%, respectively. Five-year overall survival and recurrence-free survival rates were 60.3% and 15.9%, respectively. Multivariate analysis revealed that an age of 75 years or more [relative hazard (RH) 1.61, p=0.019] and a serum albumin level less than 3.5g/dL (RH 1.61, p=0.016) were significant factors for decreased overall survival. Furthermore, a serum albumin level less than 3.5g/dL (RH 1.50, p=0.003) was the only significant factor for decreased recurrence-free survival. Conclusions: This study suggests that host-related factors (age and serum albumin level) are important in predicting survival in hepatitis C patients with a single small HCC after RFA.
|
|
|
|
| |
| |
|